| Domain | Rank | Visitors | Earning per month | Valuation |
| cipla.com | 222109 | 3,494 | 650$ | 19500$ |
| aurobindo.com | 331444 | 2,608 | 412$ | 12360$ |
| mankindpharma.com | 384262 | 1,687 | 329$ | 9870$ |
| torrentpharma.com | 455811 | 1,156 | 387$ | 11610$ |
| lupin.com | 190164 | 2,586 | 577$ | 17310$ |
| glenmarkpharma.com | 185695 | 1,665 | 356$ | 10680$ |
| drreddys.com | 219306 | 2,125 | 435$ | 13050$ |
| pharmaadda.in | 272792 | 430 | 72$ | 2160$ |
| Moz Backlinks Count | 4600 |
| Moz Page Rank | 4 |
| Domain Authority (DA) | 57.0 |
| Page Authority (PA) | 44.0 |
| Country | Rank | Pct |
|---|
| Country Name | India |
| Country Rank | 7572
-26973
|
| Daily unique visits | 2,442 |
| Daily Page Views | 9,766 |
| Income Per Day | 908 USD |
| Sunpharma.com valuation | 27240 |
| Type | Status |
| HTML 5 | 
|
| Responsive Website | 
|
| No | Text |
| 1 | Sun Pharma No. 1 Generic Company in PatientView Survey |
| No | Text |
| 1 | Earnings Call |
| 2 | The Sun Story |
| 3 | Sun Pharma on Twitter |
| No | Text |
| 1 | Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India |
| 2 | Webcast – Q4 FY22 Earnings call |
| 3 | Q4 FY22 Financial Press Release |
| 4 | Q4 FY22 Financial Results |
| 5 | Whistle Blower Policy for Sun Pharmaceutical Industries Limited & its Subsidiaries |
| 6 | Ranbaxy's Disclosure Program |
| 7 | Ranbaxy's Disclosure Policy |
| Social | Count |
| Facebook Likes | 852 |
| Reddit score | 0 |
| Pinterest Share Count | 0 |
| Vk Share Count | 0 |
| OK Share Count | 0 |